Submit Deal
All corporates
Similar corporates
Deals Overview
Market Context
Deals
Service Providers
Relationships
Portfolio (2)
Team
Sort
sigilon therapeutics inc
HQ - United States
Biotechnology
17 Mar 2020
Investment Date
£ 65 M
Deal Value
14 Aug 2023
100%
Stake
£ 244 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Rogerio Vivaldi
President and CEO
Glenn Reicin
CFO